Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C18H19ClN4O |
| Molecular Weight | 342.823 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NC=C(C#CC2=CC=C(Cl)C=C2)C(N[C@H]3CC[C@H](O)CC3)=N1
InChI
InChIKey=XBVOXAWRUIZEMG-WKILWMFISA-N
InChI=1S/C18H19ClN4O/c19-14-5-2-12(3-6-14)1-4-13-11-21-18(20)23-17(13)22-15-7-9-16(24)10-8-15/h2-3,5-6,11,15-16,24H,7-10H2,(H3,20,21,22,23)/t15-,16-
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Neurotrophic enhancers as therapy for behavioral deficits in rodent models of Huntington's disease: use of gangliosides, substituted pyrimidines, and mesenchymal stem cells. | 2006 Jun |
|
| Wide spectrum modulation by KP-544 in models relevant for neuronal survival. | 2007 Apr 16 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
9902638
Created by
admin on Sat Dec 16 18:33:23 GMT 2023 , Edited by admin on Sat Dec 16 18:33:23 GMT 2023
|
PRIMARY | |||
|
393856-87-6
Created by
admin on Sat Dec 16 18:33:23 GMT 2023 , Edited by admin on Sat Dec 16 18:33:23 GMT 2023
|
PRIMARY | |||
|
44CE82289R
Created by
admin on Sat Dec 16 18:33:23 GMT 2023 , Edited by admin on Sat Dec 16 18:33:23 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
